To summarize, Triptolide treatment inhibited the IL-1β-induced IL-8 expression by suppressing the ERK/AP-1/NF-κB signaling, which decreased ROS generation and tumor proliferation and angiogenesis of human gastric cancer AGS cells (Figure 6). The gene discussed is CXCL8; the disease is gastric cancer.